ACRIVON THERAPEUTICS

acrivon-therapeutics-logo

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success. They specifically apply its approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single-gene driver mutations or synthetic lethal contexts. The company aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials.

#SimilarOrganizations #People #Financial #Website #More

ACRIVON THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2018-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.acrivon.com

Total Employee:
11+

Status:
Active

Total Funding:
115.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins


Similar Organizations

achelios-therapeutics-logo

Achelios Therapeutics

Achelios Therapeutics is a pharmaceutical development company advancing new product concepts through preclinical and early clinical POC.

aelin-therapeutics-logo

Aelin Therapeutics

Aelin Therapeutics is a provider of a biotherapeutics platform technology called pept-ins that are intended to harnesses.

xilio-therapeutics-logo

Xilio Therapeutics

Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.

breakpoint-therapeutics-logo

Breakpoint Therapeutics

Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs.

goldfinch-biopharma-logo

Goldfinch Biopharma

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

precision-biologics-logo

Precision Biologics

Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.

relay-therapeutics-logo

Relay Therapeutics

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

semarion-logo

Semarion

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

x-biotix-therapeutics-logo

X-Biotix Therapeutics

X-Biotix Therapeutics is a biotechnology company specializing in the development of small molecule antibiotic scaffolds.


Current Advisors List

derek-dirocco_image

Derek DiRocco Board Member @ Acrivon Therapeutics
Board_member

Current Employees Featured

eric-devroe_image

Eric Devroe
Eric Devroe SVP, Business Operations @ Acrivon Therapeutics
SVP, Business Operations
2020-10-01

not_available_image

Kristina Masson
Kristina Masson Co-Founder, Co-President, SVP of Global Operations, & Site Head of subsidiary @ Acrivon Therapeutics
Co-Founder, Co-President, SVP of Global Operations, & Site Head of subsidiary

peter-blume-jensen_image

Peter Blume-Jensen
Peter Blume-Jensen President & CEO @ Acrivon Therapeutics
President & CEO
2018-04-01

Founder


not_available_image

Kristina Masson

peter-blume-jensen_image

Peter Blume-Jensen

Investors List

marshall-wace_image

Marshall Wace

Marshall Wace investment in Series B - Acrivon Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series B - Acrivon Therapeutics

pureos-bioventures_image

Pureos Bioventures

Pureos Bioventures investment in Series B - Acrivon Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series B - Acrivon Therapeutics

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series B - Acrivon Therapeutics

wellington-management_image

Wellington Management

Wellington Management investment in Series B - Acrivon Therapeutics

chione_image

Chione

Chione investment in Series B - Acrivon Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Acrivon Therapeutics

acorn-bioventures_image

Acorn Bioventures

Acorn Bioventures investment in Series B - Acrivon Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series B - Acrivon Therapeutics

Official Site Inspections

http://www.acrivon.com Semrush global rank: 3.4 M Semrush visits lastest month: 4.6 K

Unable to get host informations!!!

Loading ...

More informations about "Acrivon Therapeutics" on Search Engine